Recap: Cocrystal Pharma Q4 Earnings
Recap: Cocrystal Pharma Q4 Earnings
Cocrystal Pharma (NASDAQ:COCP) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:00 AM.
Cocrystal Pharma(納斯達克股票代碼:COCP)於2024年3月28日星期四上午08點公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Cocrystal Pharma beat estimated earnings by 27.0%, reporting an EPS of $-0.44 versus an estimate of $-0.6.
Cocrystal Pharma的收益比預期高出27.0%,每股收益爲-0.44美元,而預期爲-0.6美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.12 which was followed by a 0.0% increase in the share price the next day.
上個季度,該公司的每股收益高出0.12美元,隨後第二天股價上漲了0.0%。
** Listen to the earnings announcement yourself by clicking here. **
** 點擊此處親自收聽業績公告。**
To track all earnings releases for Cocrystal Pharma visit their earnings calendar here.
要追蹤Cocrystal Pharma發佈的所有業績,請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閱。
譯文內容由第三人軟體翻譯。